Intellectual PropertyRSS

  • August 18, 2006

    PTO Rejects 15 Claims In Synopsys Patent

    Magma Design Automation Inc. got a piece of good news when the U.S. Patent and Trademark Office rejected all 15 claims in one of three patents at issue in the suit between Magma and rival Synopsys Inc.

  • August 18, 2006

    Gloves Come Off In Plavix Battle

    Canadian generic drug maker Apotex has accused Bristol-Myers of engaging in illegal secret side deals that led to a Department of Justice investigation into a Plavix settlement agreement.

  • August 18, 2006

    RFID Case Pits Inventor Against Six Corporate Giants

    A tiny Houston-based company has dragged five corporate giants into federal court in Texas, claiming they infringed on a patent related to miniscule microchips used to keep track of inventory.

  • August 18, 2006

    In Gleevec Feud, Novartis Targets Indian Patent Rules

    In its ongoing battle to patent its cancer treatment Gleevec in India, Novartis AG has lashed out not only at the rejection of its patent application earlier this year, but at a key section of India’s recently enacted patent laws.

  • August 17, 2006

    Symbol Settles Dispute Over Batteries

    In another electrifying win for the company, Symbol Technologies Inc. put the finishing touches on its settlement with Global Technology Systems over an intellectual property dispute relating to GTS’ Honeywell batteries.

  • August 17, 2006

    Trial Slated For Monday In Wyeth Hormone Drug Case

    The first of thousands of personal injury lawsuits against Wyeth over the company’s hormone therapy drugs, which were used to treat the symptoms of menopause, is slated to begin on Monday.

  • August 17, 2006

    Honeywell $46.58 Million Jury Verdict Overturned

    A federal judge has overturned a $46.58 million jury verdict in a patent infringement case from 2001 over aircraft power unit systems.

  • August 17, 2006

    IP Partner Comes To Dechert By Way Of South Korea

    Signing on as the new partner in Dechert LLP’s Austin, Tex. office was a homecoming of sorts for Steven R. Daniels—and not just because he recently returned from South Korea.

  • August 17, 2006

    Ranbaxy Bids For Second Look In Lipitor Feud

    Swiping back in the battle over Pfizer Inc.’s Lipitor, Indian drug maker Ranbaxy Laboratories Ltd. on Wednesday asked a U.S. appeals court to reconsider part of a ruling that would block a generic version of the cholesterol medicine from hitting the market until 2010.

  • August 17, 2006

    Network Security Company Files Suit Against Rival

    DeepNines Inc., a network security solutions company, is suing rival McAfee Inc. for patent infringement in an attempt to permanently stop McAfee from selling a network security device.

  • August 16, 2006

    Trademark Dispute Sparks Rum-Fueled Courtroom Battle

    Two liquor companies have squared off in federal court in Delaware over the trademark rights to “Havana Club” after the U.S. Patent and Trademark Office declared the Cuban government’s U.S. registration of the mark null.

  • August 16, 2006

    In HIV/AIDS Fight, Tough Choices Loom For Thailand

    Weeks after protestors rallied against British drug maker GlaxoSmithKline’s efforts to patent an anti-retroviral in Thailand, the World Bank warned in a report Wednesday that the country must decide whether to shell out market prices for patented drugs as a rising number of Thais living with HIV/AIDS are forced to turn to so-called second-line drugs.

  • August 16, 2006

    Federal Circuit Sides With Monsanto In Licensing Spat

    The U.S. Court of Appeals for the Federal Circuit has partially affirmed a decision involving Monsanto Co., dismissing claims of patent misuse and antitrust violations hurled at the agrochemical giant over its Roundup Ready licensing arrangements.

  • August 16, 2006

    Fish & Richardson Nets Seasoned Litigator

    Before coming to Fish & Richardson PC earlier this month, 67-year-old IP lawyer Jonathan A. Marshall briefly considered retirement. His firm, Weil Gotshal & Manges, required its attorneys to step down once they hit 68, an age at which not many people are thinking of starting over in a new position.

  • August 16, 2006

    Bristol-Myers, Sanofi Try To Cope With Generic Plavix

    In an attempt to cope with Apotex Inc.’s recent launch of generic Plavix, Bristol-Myers Squibb Co. and Sanofi-Aventis SA are offering the buyers of Plavix prices below the price of the generic version.

  • August 16, 2006

    Mobility And Formosa Call Truce Over Power Adapters

    After years of fighting, Mobility Electronics Inc. and Formosa Electronic Industries Inc. have laid down their swords, putting to end a long-standing patent infringement battle over an array of power adapters.

  • August 15, 2006

    Shire, Barr Resolve Suits Over Generic Adderall

    Shire PLC and Barr Pharmaceuticals have made amends in a long-running patent stand-off over Barr’s efforts to market a copycat version of Shire’s blockbuster hyperactivity drug Adderall.

  • August 15, 2006

    Judge Extends Deadline In Qualcomm-Broadcom Spat

    The complicated ongoing legal wrangling between communications company Qualcomm Inc. and wireless semiconductor maker Broadcom Corp. slowed this week, with an administrative law judge opting to postpone a decision due to the complexity of the issues raised in the patent infringement case.

  • August 15, 2006

    Altnet Sues StreamCast For Patent Infringement

    While it has been accused of encouraging file-sharing, Altnet Inc. doesn’t share is its patents. The company has commenced patent infringement proceedings against StreamCast Networks Inc., maker of the once popular Morpheus P2P network, and its CEO.

  • August 15, 2006

    Abbott Slashes HIV Drug Price For Developing Nations

    Still struggling with how to protect its patent rights, drug maker Abbott Laboratories Inc. has said it will launch new initiatives aimed at expanding the availability of its new HIV medicine in the developing world.